Third dose, Pregliasco: “Israel data says it’s important”

“Israeli data” on the third dose of the anti-Covid vaccine “tell us that it is important to carry out this revaccination, especially for the frail and the exposed”. So at Adnkronos Salute the virologist Fabrizio Pregliasco, professor at the State University of Milan, commenting on the Israeli study published in the ‘New England Journal of Medicine’ which shows how with a third dose Pfizer would bring the effectiveness of the vaccine to about 95 % protection even compared to the Delta variant. “We will then see how the winter season proceeds – adds Pregliasco – to better understand what to do in terms of overall strategy for the entire population and whether to be satisfied”. But “there is a distinction – clarifies the virologist – for now we are doing the third dose on the immunosuppressed because instead of 2 they have to do 3, and the third at least 28 days after the second, for the others it is a recall from 6 months onwards “.